The following table is for layout only Goto Main Navigation | Goto Main Content | Goto Banner | Goto Logon Box | Goto Menu Bar | Goto Search Box | Goto Footer
 

 
Register
|
Return to Listing
Intravenous immunoglobulin for a 65 year old patient with pyoderma gangrenosum, for which standard treatments have failed
URL/File
 IV Immunoglobulin 1050517 Evidence revie​w summary sheet may 08.doc [78.5K] - Downloaded 6 times. Last downloaded 01 May 2012 14:40.
FormatMS Word Document (.doc)
Home LocationLHO
National or RegionalRegional
start of decorative frame for
start of content for
Publication date28 Feb 2009
Creator(s)Islington PCT
end of content for
end of decorative frame for
start of decorative frame for
start of content for
Is part of
end of content for
end of decorative frame for
start of decorative frame for
start of content for
Ustekinumab for a 16-year old with psoriasis that has failed standard treatment, including etanercept
Etanercept for patient with pyoderma gangrenosum (PG)
Intravenous immunoglobulin for delayed hyperhaemolysis syndrome following exchange transfusion in a patient with sickle cell disease
Intravenous immunoglobulin for the treatment of parainfluenza 3 virus
Etanercept for pyoderma gangrenosum
More...
end of content for
end of decorative frame for
start of decorative frame for
start of content for
KeywordsClinical exceptions
Exceptional treatments
individual treatments
IV immunoglobulin
Pyoderma gangrenosum
end of content for
end of decorative frame for
start of decorative frame for Type and Language
Type and Language
start of content for Type and Language
Resource Typereport
end of content for Type and Language
end of decorative frame for Type and Language